# Identification
**CC:** Follow-up

## Problem List
1. – stable, improving, worsening
2. – stable, improving, worsening
3. – stable, improving, worsening

## Current Meds

## Interim History
Taking and tolerating medications without daytime sedation or other side effects.  
Participating in recommended psychotherapies.  
There are no new complaints or problems reported.  
There are no new labs to review.

## Past Medical History
No changes.

## Social History
See HPI

## Family History
No changes. No knowledge of maternal/paternal family hx of sudden cardiac death/unexplained death or cardiac issues in relatives under age 50.

## ROS
General: Denies weight changes  
CVS: No CP or palpitations  
CNS: No dizziness, lightheadedness, falls, or LOC.  
ROS negative except as noted above.

Vital signs are stable.  
MM/DD/2025 Height: ___ Weight: ___ BP: ___ HR: ___

## MSE
This is an xx:x yr old boy girl. Pt is alert and fully oriented with intact memory and adequate attention during the session. Pt is well-groomed and dressed appropriately. The pt is cooperative with the interview and forthcoming with responses to questions. Eye contact is good. There is no psychomotor agitation or retardation. Speech is clearly articulated of a normal rate, rhythm, and volume. Affect is bright and consistent with stable mood reported as x/10 without suicidal or homicidal ideation, plan, or intent. Thought process is without flight of ideas, racing thoughts, or loosening of associations. Thought content is without obvious delusions or obsessions. No worries or fears were expressed. Pt denies auditory or visual hallucinations or other perceptual abnormalities. Insight and judgment are grossly intact.

## Risk Assessment
On risk assessment, client's current risk factors include depression (partial remission), comorbid XXX, h/o SIB (last several weeks ago). No prior suicide attempts. Client denies active suicidal thoughts, intent or plans. Client is living with a supportive family, is futuristic in thinking, no access to firearms, family providing close supervision, engaged in therapy (individual), compliant with medications, parents have removed sharps and pills, no active substance use, no global insomnia. Client is using coping skills for emotional dysregulation. Therefore, current risk low. Patient is not imminently suicidal, with intent or plans, and can be maintained on current treatment level of care at this time.

## Assessment
The patient has current stressors that exacerbate his psychiatric symptoms in the form of x, y, and z. The patient has had some improvements in x symptoms while on y. The patient is not imminently suicidal or homicidal, with intent or plan. Patient may continued to be followed on an outpatient basis.

## Plan
> Discussed diagnoses, clinical impressions, and treatment recommendations.  
> Parents consented, client assented to treatment.  
> Parents / client agrees with treatment plan that includes medication management and outpatient therapy.  
> Latest physical exam in chart and reviewed. No contraindications to recommended treatment.  
> Reviewed current medications and checked for possible interactions.  
> Risks, benefits, and appropriate use of prescribed medications were clearly discussed. The medications are administered with the consent of the parent & assent of patient.  
> After discussion of treatment options, we have decided to start …

… start a trial of medication for ADHD; will start at 10mg every morning for 1 week, then increase to 20mg daily. PDMP checked. E-script x 30 day supply placed.

… start a trial of SSRI for depression; Prozac 10mg daily for 2 week, then increase 20mg daily. We discussed FDA blackbox warning for suicidal thoughts and behavior. E-script x 30 day (#53 10mg caps) supply placed.

… start a trial of SSRI for anxiety; Zoloft 25mg daily for 2 week, then increase to 50mg daily. We discussed FDA blackbox warning for suicidal thoughts and behavior. Family aware it is off label. E-script x 30 day (#45 x 25mg tabs) supply placed.

… start a trial of SSRI for OCD; Zoloft 25mg daily for 2 week, then increase to 50mg daily. We discussed FDA blackbox warning for suicidal thoughts and behavior. E-script x 30 day (#45 x 25mg tabs) supply placed.

> Psychoeducation provided on sleep hygiene. Patient to utilize improved sleep hygiene and increase sleep. Client to start using noise machine / noise app.  
> Client to start using pharmaceutical grade melatonin 3-5mg 30 minutes before sleep.  
> Client to start fish oil (omega 3 FA's) at least 1000mg daily (with 400mg EPA and 200mg DHA) for ADHD and irritability.  
> Outpatient therapy is recommended. A CBT, IPT, or psychodynamic approach may be most productive. As client currently in therapy, recommended increase in frequency to 2x/week.  
> Family therapy may be helpful to reduce conflict as this is a major stressor for the patient. Family is interested at this time.  
> Follow-up in x weeks; MMM/DD/YYYY.

## Therapy Notes
N/a Client discussed

---

Signed by Samir V. Tarpara, MD on MMM/DD/YYYY